MedCity News August 13, 2025
This article is part of a series on eliminating blind spots in the patient journey by leveraging real-world data.
Although most diseases are well defined, the patent experience for those who have the same condition can differ dramatically for a multitude of reasons. The physical and psychological impact on patients are significant. Comorbidities, genetics, financial standing, social life, ethnicity, life experiences, environmental factors also play a role. That’s why clinicians and pharma companies need to consider real-world data (RWD) for drug development. Without this crucial information, clinicians and drug developers create “blind spots” that prevent them from fully understanding the condition and what’s needed for effective treatments. A recent webinar hosted by MedCity News and PurpleLab explored the importance of...
Today's Sponsors
Today's Sponsor